Xanthine oxidase (XO) is an important target for the treatment of hyperuricemia and gout. Based on the two known non-purine xanthine oxidase inhibitors, febuxostat and topiroxostat, 14 oxadiazole derivatives have been designed and synthesized. These compounds have been evaluated against XO and five of them exhibited significant inhibitory activities at the concentrations below 10 μmol·L(-1).
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
xanthine oxidase
12
oxadiazole derivatives
8
[design synthesis
4
synthesis biological
4
biological evaluation
4
evaluation oxadiazole
4
derivatives xanthine
4
oxidase inhibitors]
4
inhibitors] xanthine
4
oxidase target
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!